Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.

Lee SJ, Lee YJ, Lee K, Cho DK, Cho YH, Ahn SG, Yun KH, Jang JY, Kim S, Kim YH, Park YH, Kwon SU, Hur SH, Kang TS, Shin ES, Lee JB, Jeon KH, Kim U, Kim WH, Hong BK, Lee SH, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Kim BK, A-CLOSE investigators.

Open source

DOI: 10.1056/nejmoa2608533
Published: 2026-08-29
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2608533,
  title = {Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.},
  author = {Lee SJ and  Lee YJ and  Lee K and  Cho DK and  Cho YH and  Ahn SG and  Yun KH and  Jang JY and  Kim S and  Kim YH and  Park YH and  Kwon SU and  Hur SH and  Kang TS and  Shin ES and  Lee JB and  Jeon KH and  Kim U and  Kim WH and  Hong BK and  Lee SH and  Hong SJ and  Ahn CM and  Kim JS and  Ko YG and  Choi D and  Hong MK and  Jang Y and  Kim BK and  A-CLOSE investigators.},
  year = {2026},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2608533},
  url = {https://doi.org/10.1056/nejmoa2608533}
}

RIS

TY  - JOUR
TI  - Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.
AU  - Lee SJ
AU  -  Lee YJ
AU  -  Lee K
AU  -  Cho DK
AU  -  Cho YH
AU  -  Ahn SG
AU  -  Yun KH
AU  -  Jang JY
AU  -  Kim S
AU  -  Kim YH
AU  -  Park YH
AU  -  Kwon SU
AU  -  Hur SH
AU  -  Kang TS
AU  -  Shin ES
AU  -  Lee JB
AU  -  Jeon KH
AU  -  Kim U
AU  -  Kim WH
AU  -  Hong BK
AU  -  Lee SH
AU  -  Hong SJ
AU  -  Ahn CM
AU  -  Kim JS
AU  -  Ko YG
AU  -  Choi D
AU  -  Hong MK
AU  -  Jang Y
AU  -  Kim BK
AU  -  A-CLOSE investigators.
PY  - 2026
JO  - N Engl J Med
DO  - 10.1056/nejmoa2608533
UR  - https://doi.org/10.1056/nejmoa2608533
ER  -

APA

SJ, L., YJ, L., K, L., DK, C., YH, C., SG, A., KH, Y., JY, J., S, K., YH, K., YH, P., SU, K., SH, H., TS, K., ES, S., JB, L., KH, J., U, K., WH, K., BK, H., SH, L., SJ, H., CM, A., JS, K., YG, K., D, C., MK, H., Y, J., BK, K., & investigators., A. (2026). Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.. N Engl J Med. https://doi.org/10.1056/nejmoa2608533

Source records

europe-pmc · retrieved 2026-09-26T20:29:25.542Z